FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Lehrstuhl für Innere Medizin IV
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 4 – Nephrology and Hypertension
Overview
Publications
(735)
Research Grants
(31)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Comeback of Renal Denervation As Treatment Option in Patients with Hypertension (2019)
Jung S, Schmieder R
Journal article
Implementation of Bayesian Study Design in the SPYRAL HTN-OFF MED Pivotal Trial (2019)
Boehm M, Townsend R, Weber M, Kandzari D, Mahfoud F, Kario K, Schmieder R, et al.
Conference contribution
Association of donor hypertension and recipient renal function in living donor kidney transplantation: A single-center retrospective study (2019)
Dienemann T, Schellenberg J, Heller K, Daniel C, Amann KU, Hilgers KF, Schiffer M, Weidemann A
Journal article
The nephrology eHealth-system of the metropolitan region of Hannover for digitalization of care, establishment of decision support systems and analysis of health care quality (2019)
Pape L, Schneider N, Schleef T, Junius-Walker U, Haller H, Brunkhorst R, Hellrung N, et al.
Journal article
Estimated GFR (eGFR) loss with glucagon-like peptide-1 (GLP-1) analogue treatment: data from SUSTAIN 6 and LEADER (2019)
Perkovic V, Bain SC, Bakris G, Buse JB, Gondolf T, Idorn T, Lausvig N, et al.
Conference contribution
Impact of microvascular disease on cardiorenal outcomes in type 2 diabetes: an analysis from the LEADER and SUSTAIN 6 clinical trials (2019)
Zinman B, Verma S, Bain SC, Honore JB, Mann J, Nauck MA, Pratley R, et al.
Conference contribution
Tissue sodium concentration correlates with hypertrophic vascular remodelling in type 2 diabetes (2019)
Kannenkeril D, Jung S, Harazny J, Striepe K, Ott C, Linz P, Nagel AM, et al.
Conference contribution
Pleiotropic effects under combined therapy with empagliflozin and linagliptin compared to metformin and insulin glargine in patients with type 2 diabetes (2019)
Jung S, Ott C, Kannenkeril D, Bosch A, Karg M, Striepe K, Bramlage P, Schmieder R
Conference contribution
Disparate effects of the combined therapy of empagliflozin and linagliptin versus metformin and insulin glargine on renal haemodynamics in type 2 diabetes (2019)
Ott C, Jung S, Kannenkeril D, Striepe K, Bosch A, Korn M, Bramlage P, Schmieder R
Conference contribution
Interleukin-1 beta activates essential checkpoints in the formation of lung-resident memory T cell (2019)
Lapuente D, Fuchs J, Maier C, Bonsmann MSG, Maaske A, Stab V, Heinecke V, et al.
Conference contribution
‹
1
...
35
36
37
38
39
...
74
›